{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:40:35Z","timestamp":1760964035409,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.soc.2018.02.004","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T23:22:10Z","timestamp":1529536930000},"page":"463-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Genomics of Peritoneal Malignancies"],"prefix":"10.1016","volume":"27","author":[{"given":"Enusha","family":"Karunasena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Sham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin Wyatt","family":"McMahon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nita","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.soc.2018.02.004_bib1","first-page":"177","article-title":"Colorectal cancer statistics, 2017","volume":"67","author":"Siegel","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.amjsurg.2016.03.008","article-title":"Peritoneal carcinomatosis of colorectal cancer: novel clinical and molecular outcomes","volume":"213","author":"Massalou","year":"2017","journal-title":"Am J Surg"},{"issue":"24","key":"10.1016\/j.soc.2018.02.004_bib3","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1002\/cncr.25356","article-title":"Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy: a multi-institutional study of 1,290 patients","volume":"116","author":"Glehen","year":"2010","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib4","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju121","article-title":"TP53 mutational status and cetuximab benefit in rectal cancer: 5-year results of the EXPERT-C trial","volume":"106","author":"Sclafani","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.soc.2018.02.004_bib5","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1053\/j.gastro.2009.12.065","article-title":"The chromosomal instability pathway in colon cancer","volume":"138","author":"Pino","year":"2010","journal-title":"Gastroenterology"},{"issue":"17","key":"10.1016\/j.soc.2018.02.004_bib6","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1056\/NEJMoa0804385","article-title":"K-ras mutations and benefit from cetuximab in advanced colorectal cancer","volume":"359","author":"Karapetis","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.soc.2018.02.004_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1470-2045(10)70130-3","article-title":"Effects of KRAS, BRAF, NRAS, and\u00a0PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis","volume":"11","author":"De Roock","year":"2010","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.soc.2018.02.004_bib8","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1136\/gutjnl-2012-302423","article-title":"A\u00a0combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment prediction","volume":"62","author":"Tian","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.soc.2018.02.004_bib9","doi-asserted-by":"crossref","first-page":"6870","DOI":"10.1073\/pnas.95.12.6870","article-title":"Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma","volume":"95","author":"Herman","year":"1998","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"52","key":"10.1016\/j.soc.2018.02.004_bib10","doi-asserted-by":"crossref","first-page":"86480","DOI":"10.18632\/oncotarget.13441","article-title":"Tumors with unmethylated MLH1 and the CpG island methylator phenotype are associated with a poor prognosis in stage II colorectal cancer patients","volume":"7","author":"Fu","year":"2016","journal-title":"Oncotarget"},{"issue":"11","key":"10.1016\/j.soc.2018.02.004_bib11","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/mc.20566","article-title":"MSH6 G39E polymorphism and CpG island methylator phenotype in colon cancer","volume":"48","author":"Curtin","year":"2009","journal-title":"Mol Carcinog"},{"issue":"17","key":"10.1016\/j.soc.2018.02.004_bib12","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1158\/1078-0432.CCR-12-0707","article-title":"CpG island methylator phenotype-positive tumors in the absence of MLH1 methylation constitute a distinct subset of duodenal adenocarcinomas and are associated with poor prognosis","volume":"18","author":"Fu","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"6349","key":"10.1016\/j.soc.2018.02.004_bib13","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch-repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","author":"Le","year":"2017","journal-title":"Science"},{"issue":"6392","key":"10.1016\/j.soc.2018.02.004_bib14","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/359235a0","article-title":"APC mutations occur early during colorectal tumorigenesis","volume":"359","author":"Powell","year":"1992","journal-title":"Nature"},{"issue":"19","key":"10.1016\/j.soc.2018.02.004_bib15","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM200011093431901","article-title":"Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents","volume":"343","author":"Esteller","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.soc.2018.02.004_bib16","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1101\/gad.7.8.1572","article-title":"Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation","volume":"7","author":"Xiong","year":"1993","journal-title":"Genes Dev"},{"issue":"20","key":"10.1016\/j.soc.2018.02.004_bib17","first-page":"4548","article-title":"Inhibition by phenyl N-tert-butyl nitrone of early phase carcinogenesis in the livers of rats fed a choline-deficient, L-amino acid-defined diet","volume":"58","author":"Nakae","year":"1998","journal-title":"Cancer Res"},{"issue":"23","key":"10.1016\/j.soc.2018.02.004_bib18","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1038\/sj.onc.1205466","article-title":"K-ras mutations and RASSF1A promoter methylation in colorectal cancer","volume":"21","author":"van Engeland","year":"2002","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/ng0501-4","article-title":"Knocking the SOCS off a tumor suppressor","volume":"28","author":"Kishimoto","year":"2001","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.soc.2018.02.004_bib20","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1093\/carcin\/bgi058","article-title":"CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype","volume":"26","author":"Brandes","year":"2005","journal-title":"Carcinogenesis"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib21","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/sj.onc.1207263","article-title":"Epigenetic silencing of the adhesion molecule ADAM23 is highly frequent in breast tumors","volume":"23","author":"Costa","year":"2004","journal-title":"Oncogene"},{"issue":"54","key":"10.1016\/j.soc.2018.02.004_bib22","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1038\/sj.onc.1208952","article-title":"ADAM23, a possible tumor suppressor gene, is frequently silenced in gastric cancers by homozygous deletion or aberrant promoter hypermethylation","volume":"24","author":"Takada","year":"2005","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.soc.2018.02.004_bib23","doi-asserted-by":"crossref","first-page":"6029","DOI":"10.1158\/0008-5472.CAN-05-0137","article-title":"MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells","volume":"65","author":"Chan","year":"2005","journal-title":"Cancer Res"},{"issue":"39","key":"10.1016\/j.soc.2018.02.004_bib24","doi-asserted-by":"crossref","first-page":"15472","DOI":"10.1073\/pnas.0707351104","article-title":"Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells","volume":"104","author":"Tazawa","year":"2007","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.soc.2018.02.004_bib25","doi-asserted-by":"crossref","first-page":"43393","DOI":"10.1038\/srep43393","article-title":"MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer","volume":"7","author":"Miyoshi","year":"2017","journal-title":"Sci Rep"},{"issue":"46","key":"10.1016\/j.soc.2018.02.004_bib26","doi-asserted-by":"crossref","first-page":"6170","DOI":"10.1038\/sj.onc.1209911","article-title":"MicroRNAs and the hallmarks of cancer","volume":"25","author":"Dalmay","year":"2006","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.soc.2018.02.004_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5483\/BMBRep.2015.48.4.007","article-title":"MicroRNAs: promising biomarkers for diagnosis and therapeutic targets in human colorectal cancer metastasis","volume":"48","author":"Hur","year":"2015","journal-title":"BMB Rep"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF02236899","article-title":"Appendiceal tumors: retrospective clinicopathologic analysis of appendiceal tumors from 7,970 appendectomies","volume":"41","author":"Connor","year":"1998","journal-title":"Dis Colon Rectum"},{"issue":"12","key":"10.1016\/j.soc.2018.02.004_bib29","doi-asserted-by":"crossref","first-page":"3307","DOI":"10.1002\/cncr.10589","article-title":"Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998","volume":"94","author":"McCusker","year":"2002","journal-title":"Cancer"},{"issue":"10","key":"10.1016\/j.soc.2018.02.004_bib30","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1007\/BF02554625","article-title":"Malignant pseudomyxoma peritonei of colonic origin. Natural history and presentation of a curative approach to treatment","volume":"30","author":"Sugarbaker","year":"1987","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib31","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bjs.4862","article-title":"Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei","volume":"92","author":"Bryant","year":"2005","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.soc.2018.02.004_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/gm559","article-title":"Genome-wide mutational landscape of mucinous carcinomatosis peritonei of appendiceal origin","volume":"6","author":"Alakus","year":"2014","journal-title":"Genome Med"},{"key":"10.1016\/j.soc.2018.02.004_bib34","first-page":"50","article-title":"Immunohistochemistry - microarray analysis of patients with peritoneal metastases of appendiceal or colorectal origin","volume":"1","author":"Green","year":"2014","journal-title":"Front Surg"},{"issue":"11","key":"10.1016\/j.soc.2018.02.004_bib35","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/annonc\/mdw314","article-title":"Toward the molecular dissection of peritoneal pseudomyxoma","volume":"27","author":"Pietrantonio","year":"2016","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib36","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1373\/clinchem.2014.225565","article-title":"Molecular profiling of appendiceal epithelial tumors using massively parallel sequencing to identify somatic mutations","volume":"60","author":"Liu","year":"2014","journal-title":"Clin Chem"},{"issue":"3","key":"10.1016\/j.soc.2018.02.004_bib37","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/1097-4652(200012)185:3<408::AID-JCP11>3.0.CO;2-2","article-title":"Protein kinase-A-mediated secretion of mucin from human colonic epithelial cells","volume":"185","author":"Bradbury","year":"2000","journal-title":"J\u00a0Cell Physiol"},{"issue":"Pt 3","key":"10.1016\/j.soc.2018.02.004_bib38","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1042\/bj3040675","article-title":"Cyclic AMP-induced mucin exocytosis is independent of Cl- movements in human colonic epithelial cells (HT29-Cl.16E)","volume":"304","author":"Jarry","year":"1994","journal-title":"Biochem J"},{"issue":"6","key":"10.1016\/j.soc.2018.02.004_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1161\/01.RES.0000241428.82502.d4","article-title":"Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils: implication of A2a receptor and cAMP\/PKA\/Ca2+ pathway","volume":"99","author":"Ernens","year":"2006","journal-title":"Circ Res"},{"issue":"5","key":"10.1016\/j.soc.2018.02.004_bib40","doi-asserted-by":"crossref","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012","volume":"136","author":"Ferlay","year":"2015","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib41","doi-asserted-by":"crossref","first-page":"8055","DOI":"10.18632\/oncotarget.6977","article-title":"Genetic alterations and their clinical implications in gastric cancer peritoneal carcinomatosis revealed by whole-exome sequencing of malignant ascites","volume":"7","author":"Lim","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib42","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4251\/wjgo.v2.i1.12","article-title":"Pathophysiology and biology of peritoneal carcinomatosis","volume":"2","author":"Kusamura","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.soc.2018.02.004_bib43","first-page":"21","article-title":"Molecular biology of peritoneal carcinomatosis","volume":"134","author":"Jayne","year":"2007","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.soc.2018.02.004_bib44","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1038\/srep13750","article-title":"Whole genome and transcriptome sequencing of matched primary and peritoneal metastatic gastric carcinoma","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.soc.2018.02.004_bib45","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00428-012-1300-5","article-title":"Cartilage tumour progression is characterized by an increased expression of heparan sulphate 6O-sulphation-modifying enzymes","volume":"461","author":"Waaijer","year":"2012","journal-title":"Virchows Arch"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/13651820500472200","article-title":"Surgical treatment of liver metastases from pancreatic cancer","volume":"8","author":"Yamada","year":"2006","journal-title":"HPB (Oxford)"},{"issue":"11","key":"10.1016\/j.soc.2018.02.004_bib47","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib48","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"issue":"5897","key":"10.1016\/j.soc.2018.02.004_bib49","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1126\/science.1164368","article-title":"Core signaling pathways in human pancreatic cancers revealed by global genomic analyses","volume":"321","author":"Jones","year":"2008","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.soc.2018.02.004_bib50","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat Med"},{"issue":"10","key":"10.1016\/j.soc.2018.02.004_bib51","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor- and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat Genet"},{"issue":"7592","key":"10.1016\/j.soc.2018.02.004_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"issue":"7540","key":"10.1016\/j.soc.2018.02.004_bib53","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.soc.2018.02.004_bib54","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1158\/2159-8290.CD-15-0120","article-title":"Pancreatic cancer metastases harbor evidence of polyclonality","volume":"5","author":"Maddipati","year":"2015","journal-title":"Cancer Discov"},{"issue":"7319","key":"10.1016\/j.soc.2018.02.004_bib55","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.soc.2018.02.004_bib56","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat Genet"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib57","doi-asserted-by":"crossref","first-page":"C444","DOI":"10.1152\/ajpcell.00188.2015","article-title":"Cellular and molecular processes in ovarian cancer metastasis. A review in the theme: cell and molecular processes in cancer metastasis","volume":"309","author":"Yeung","year":"2015","journal-title":"Am J Physiol Cell Physiol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib58","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"issue":"12","key":"10.1016\/j.soc.2018.02.004_bib59","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1002\/cncr.21536","article-title":"BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases","volume":"104","author":"Pal","year":"2005","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.soc.2018.02.004_bib60","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/humu.20599","article-title":"Contribution of BRCA1 and BRCA2 mutations to inherited ovarian cancer","volume":"28","author":"Ramus","year":"2007","journal-title":"Hum Mutat"},{"issue":"7353","key":"10.1016\/j.soc.2018.02.004_bib61","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/nature10166","article-title":"Integrated genomic analyses of ovarian carcinoma","volume":"474","year":"2011","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.soc.2018.02.004_bib62","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/ng.3826","article-title":"Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer","volume":"49","author":"Phelan","year":"2017","journal-title":"Nat Genet"},{"issue":"9","key":"10.1016\/j.soc.2018.02.004_bib63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1038\/bjc.2017.297","article-title":"Crosstalk between TEMs and endothelial cells modulates angiogenesis and metastasis via IGF1-IGF1R signalling in epithelial ovarian cancer","volume":"117","author":"Wang","year":"2017","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib64","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.4049\/jimmunol.175.2.1197","article-title":"Macrophages induce invasiveness of epithelial cancer cells via NF-\u03baB and JNK","volume":"175","author":"Hagemann","year":"2005","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1479-5876-4-30","article-title":"Monocyte\/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease","volume":"4","author":"Wang","year":"2006","journal-title":"J\u00a0Transl Med"},{"issue":"3","key":"10.1016\/j.soc.2018.02.004_bib66","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11864-016-0389-1","article-title":"New approaches for immune directed treatment for ovarian cancer","volume":"17","author":"Hardwick","year":"2016","journal-title":"Curr Treat Options Oncol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib67","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2015.08.010","article-title":"Hepatocyte growth factor secreted by ovarian cancer cells stimulates peritoneal implantation via the mesothelial-mesenchymal transition of the peritoneum","volume":"139","author":"Nakamura","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1016\/j.soc.2018.02.004_bib68","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.2353\/ajpath.2010.100105","article-title":"Ovarian cancer development and metastasis","volume":"177","author":"Lengyel","year":"2010","journal-title":"Am J Pathol"},{"issue":"2","key":"10.1016\/j.soc.2018.02.004_bib69","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yexmp.2015.07.005","article-title":"Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing","volume":"99","author":"Putra","year":"2015","journal-title":"Exp Mol Pathol"},{"issue":"9","key":"10.1016\/j.soc.2018.02.004_bib70","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1634\/theoncologist.2015-0210","article-title":"Prognosis and clinicopathologic features of patients with advanced stage isocitrate dehydrogenase (IDH) mutant and IDH wild-type intrahepatic cholangiocarcinoma","volume":"20","author":"Goyal","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.soc.2018.02.004_bib71","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"7","key":"10.1016\/j.soc.2018.02.004_bib72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1158\/2159-8290.CD-15-1442","article-title":"Isocitrate dehydrogenase mutations confer dasatinib hypersensitivity and SRC dependence in intrahepatic cholangiocarcinoma","volume":"6","author":"Saha","year":"2016","journal-title":"Cancer Discov"},{"issue":"117","key":"10.1016\/j.soc.2018.02.004_bib73","first-page":"373","article-title":"Targeting isocitrate dehydrogenase (IDH) in cancer","volume":"21","author":"Fujii","year":"2016","journal-title":"Discov Med"},{"issue":"25","key":"10.1016\/j.soc.2018.02.004_bib74","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.soc.2018.02.004_bib75","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1056\/NEJMoa0808710","article-title":"IDH1 and IDH2 mutations in gliomas","volume":"360","author":"Yan","year":"2009","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.soc.2018.02.004_bib76","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.18632\/oncotarget.1408","article-title":"5-azacytidine reduces methylation, promotes differentiation and induces tumor regression in a patient-derived IDH1 mutant glioma xenograft","volume":"4","author":"Borodovsky","year":"2013","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.soc.2018.02.004_bib77","doi-asserted-by":"crossref","first-page":"E77","DOI":"10.1002\/ajh.23965","article-title":"Presence of isocitrate dehydrogenase mutations may predict clinical response to hypomethylating agents in patients with acute myeloid leukemia","volume":"90","author":"Emadi","year":"2015","journal-title":"Am J Hematol"},{"issue":"17","key":"10.1016\/j.soc.2018.02.004_bib78","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1056\/NEJMcp1411029","article-title":"Clinical practice. Uterine fibroids","volume":"372","author":"Stewart","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.soc.2018.02.004_bib79","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrg2901","article-title":"The metazoan Mediator co-activator complex as an integrative hub for transcriptional regulation","volume":"11","author":"Malik","year":"2010","journal-title":"Nat Rev Genet"},{"issue":"6053","key":"10.1016\/j.soc.2018.02.004_bib80","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1126\/science.1208930","article-title":"MED12, the mediator complex subunit 12 gene, is mutated at high frequency in uterine leiomyomas","volume":"334","author":"Makinen","year":"2011","journal-title":"Science"},{"issue":"29","key":"10.1016\/j.soc.2018.02.004_bib81","doi-asserted-by":"crossref","first-page":"20955","DOI":"10.1074\/jbc.M113.486746","article-title":"Mediator complex recruits epigenetic regulators via its two cyclin-dependent kinase subunits to repress transcription of immune response genes","volume":"288","author":"Tsutsui","year":"2013","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3892\/or.2016.5274","article-title":"Potential role of BCL2 in the recurrence of uterine smooth muscle tumors of uncertain malignant potential","volume":"37","author":"Conconi","year":"2017","journal-title":"Oncol Rep"},{"issue":"1","key":"10.1016\/j.soc.2018.02.004_bib83","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ygyno.2004.09.026","article-title":"Expression of p16 protein in patients with uterine smooth muscle tumors: an immunohistochemical analysis","volume":"96","author":"Bodner-Adler","year":"2005","journal-title":"Gynecol Oncol"},{"issue":"10","key":"10.1016\/j.soc.2018.02.004_bib84","first-page":"2072","article-title":"Targeted next-generation sequencing of cancer genes identified frequent TP53 and ATRX mutations in leiomyosarcoma","volume":"7","author":"Yang","year":"2015","journal-title":"Am J Transl Res"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320718300140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320718300140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T12:02:17Z","timestamp":1760961737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320718300140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":84,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1055320718300140"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2018.02.004","relation":{},"ISSN":["1055-3207"],"issn-type":[{"type":"print","value":"1055-3207"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genomics of Peritoneal Malignancies","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2018.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}